Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07256951 · ClinicalTrials.gov registry record · NA
Gen 2 Battrode Wear Study
A NA study of Adhesive Wear Time, sponsored by Baxter Healthcare Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07256951: Recruiting NA study of Adhesive Wear Time, sponsored by Baxter Healthcare Corporation.
NCT07256951 is a NA study of Adhesive Wear Time that is actively recruiting participants, run by Baxter Healthcare Corporation. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07256951, a NA study of Adhesive Wear Time, is actively recruiting participants, sponsored by Baxter Healthcare Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Validating adhesive wear time
Conditions Studied
Interventions
- DEVICE Adhesive
Study Locations (1)
California
- Orange County Research Center - Lake Forest
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-11-12 |
| Est. Completion | 2026-05-15 |
| Phase | NA |
What NCT07256951 shows while recruiting
NCT07256951 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Adhesive Wear Time appearing as the primary indexed condition, and to 1 intervention - of which Adhesive is the first listed.
NCT07256951 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07256951 about?
NCT07256951 is a clinical study titled "Gen 2 Battrode Wear Study". Validating adhesive wear time
What is the current status of trial NCT07256951?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-11-12. Estimated completion is 2026-05-15.
What conditions does trial NCT07256951 study?
This clinical trial studies the following conditions: Adhesive Wear Time.
What interventions are being tested in trial NCT07256951?
The interventions under investigation include: Adhesive (DEVICE).
Who is sponsoring clinical trial NCT07256951?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07256951 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07256951's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI